Septerna (SEPN) EBITDA Margin (2023 - 2026)

Septerna (SEPN) recorded quarterly EBITDA Margin of 37.07% in Q1 2026, down 121.28% quarter-over-quarter from 174.19% in Q4 2025, and up 970448.0% on a YoY basis from N/an in Q1 2025.

Septerna (SEPN) EBITDA Margin (2023 - 2026) Analysis & Trends

Septerna's EBITDA Margin history runs 4 years deep, the most recent figure standing at 37.07% for Q1 2026.

  • In Q1 2026, EBITDA Margin rose 970448.0% year-over-year to 37.07%; the TTM figure through Mar 2026 stood at 21.74% (up 850004.0% YoY), while the FY2025 annual figure was 22.33%, up 749609.0% from the prior year.
  • EBITDA Margin was 37.07% for Q1 2026 at Septerna, down from 174.19% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 29082.2% in Q4 2023 to a low of 33166.67% in Q3 2023.
  • Historically, EBITDA Margin has averaged 6061.01% across 4 years, with a median of 4470.98% in 2024.
  • Biggest YoY gain for EBITDA Margin was 2161042 bps in 2024; the steepest drop was 4074164 bps in 2024.
  • A 4-year view of EBITDA Margin shows it stood at 29082.2% in 2023, then slumped by 140 bps to 11659.43% in 2024, then surged by 101 bps to 174.19% in 2025, then sank by 121 bps to 37.07% in 2026.
  • The last three EBITDA Margin figures came in at 37.07% (Q1 2026), 174.19% (Q4 2025), and 38.95% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -6.43%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 38.10%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Septerna 1.37 Bn 1.37 Bn - -37.07%

Historic Data

Download Data
DateValue
Mar 31, 2026 -37.07%
Dec 31, 2025 174.19%
Sep 30, 2025 38.95%
Jun 30, 2025 -20,890.76%
Mar 31, 2025 -9,741.55%
Dec 31, 2024 -11,659.43%
Sep 30, 2024 -11,556.25%
Jun 30, 2024 -4,443.78%
Mar 31, 2024 -4,470.98%
Dec 31, 2023 29,082.20%
Sep 30, 2023 -33,166.67%